mDataType,dataset_name,drug_name,sens_stat,estimate,pvalue,drug_id,tissue mRNA,CTRPv2,ML162,AAC,-0.272212882151876,3.9475486923065e-16,453,pan-cancer mRNA,CTRPv2,1S,3R-RSL-3,AAC,-0.261420767052916,1.70887529720825e-15,4,pan-cancer mRNA,CTRPv2,ML210,AAC,-0.240920725096081,2.09964049820217e-13,455,pan-cancer mRNA,CTRPv2,necrosulfonamide,AAC,-0.269344298653912,2.06810039443452e-12,484,pan-cancer mRNA,CTRPv2,PL-DI,AAC,-0.218199205520055,3.17472645458582e-12,565,pan-cancer mRNA,CTRPv2,piperlongumine,AAC,-0.205423661888402,1.35643172239749e-10,562,pan-cancer mRNA,CTRPv2,SMER-3,AAC,-0.226783323795316,3.48785664544055e-09,646,pan-cancer mRNA,CTRPv2,Cerulenin,AAC,-0.193414796840459,4.82556749435853e-09,213,pan-cancer mRNA,CTRPv2,methylstat,AAC,-0.237135839175161,9.90691460828131e-09,439,pan-cancer mRNA,CTRPv2,BRD-K34222889,AAC,-0.177905199674006,1.25601477114242e-08,133,pan-cancer mRNA,CCLE,paclitaxel,AAC,0.248017786857964,2.60560179579028e-08,526,pan-cancer mRNA,CTRPv2,BRD-K94991378,AAC,-0.214989858708969,3.69375861224075e-08,170,pan-cancer mRNA,CTRPv2,PX-12,AAC,-0.155869687940973,5.57175252388062e-08,577,pan-cancer mRNA,CTRPv2,BRD-K71935468,AAC,-0.206744043626887,7.78367427173033e-08,159,pan-cancer mRNA,CTRPv2,prima-1,AAC,-0.153112403736171,1.28501869486255e-06,570,pan-cancer mRNA,CCLE,17-AAG,AAC,0.210120993885674,5.42577003534928e-06,3,pan-cancer mRNA,CTRPv2,piperlongumine:MST-312 (1:1 mol/mol),AAC,-0.15874452342207,9.60711795508232e-06,563,pan-cancer mRNA,CTRPv2,manumycin A,AAC,-0.139928661996183,1.4048406240768e-05,432,pan-cancer mRNA,CTRPv2,CAY10618,AAC,-0.1514398855557,1.6109718581409e-05,203,pan-cancer mRNA,CTRPv2,YM-155,AAC,-0.163661792195576,1.69811284098161e-05,752,pan-cancer mRNA,GDSC1000,rTRAIL,AAC,0.150467707325112,1.87234704275417e-05,601,pan-cancer mRNA,CTRPv2,erastin,AAC,-0.149897508428579,2.15395010799192e-05,284,pan-cancer mRNA,CTRPv2,WP1130,AAC,-0.150036655185195,2.32980277318678e-05,734,pan-cancer mRNA,GDSC1000,QL-XII-47,AAC,-0.136912106527027,3.09049912821707e-05,584,pan-cancer mRNA,GDSC1000,QL-X-138,AAC,-0.128772184410841,3.11977876787298e-05,582,pan-cancer mRNA,GDSC1000,PI-103,AAC,-0.122046958035685,6.98275977466548e-05,558,pan-cancer mRNA,CTRPv2,MST-312,AAC,-0.139151525538343,7.60547562547627e-05,469,pan-cancer mRNA,CTRPv2,PI-103,AAC,-0.139015251237485,8.35394340422771e-05,558,pan-cancer mRNA,CCLE,TKI258,AAC,0.179028326465119,0.000111982520280079,694,pan-cancer mRNA,GDSC1000,OSI-027,AAC,-0.120190004308074,0.000124563613062574,518,pan-cancer mRNA,GDSC1000,Nilotinib,AAC,0.132627394224136,0.000313748424922908,491,pan-cancer mRNA,CCLE,Panobinostat,AAC,0.147403409999854,0.000317635273960719,529,pan-cancer mRNA,CTRPv2,Bortezomib,AAC,-0.12611958199549,0.000326463345010192,92,pan-cancer mRNA,GDSC1000,Imatinib,AAC,0.194517005340909,0.000379564953549271,361,pan-cancer mRNA,CTRPv2,fingolimod,AAC,-0.123608699564764,0.000562382154901706,297,pan-cancer mRNA,CTRPv2,SID 26681509,AAC,-0.132026698254811,0.00060308407848877,635,pan-cancer mRNA,CTRPv2,MLN2238,AAC,-0.117185943677796,0.000683208589763639,462,pan-cancer mRNA,CTRPv2,BRD-K13185470,AAC,0.226132769493353,0.000793918967923202,111,pan-cancer mRNA,CTRPv2,pifithrin-mu,AAC,-0.116778007958458,0.00092788678550902,560,pan-cancer mRNA,GDSC1000,thapsigargin,AAC,0.114620767777356,0.00119685685071777,686,pan-cancer mRNA,CTRPv2,BRD-K34099515,AAC,0.239531614330728,0.00126918687538966,132,pan-cancer mRNA,CTRPv2,NSC95397,AAC,-0.105307178128991,0.00170428880188686,504,pan-cancer mRNA,GDSC1000,(5Z)-7-Oxozeaenol,AAC,-0.0963524769386306,0.00196195677646717,1,pan-cancer mRNA,GDSC1000,17-AAG,AAC,0.0994412126311237,0.00198058691371668,3,pan-cancer mRNA,CTRPv2,RITA,AAC,0.10995352209262,0.00218526502479862,597,pan-cancer mRNA,GDSC1000,Mitomycin-C,AAC,0.108668066035533,0.00224240577194725,445,pan-cancer mRNA,CTRPv2,NSC632839,AAC,-0.104611412863595,0.00226781001052149,502,pan-cancer mRNA,GDSC1000,Sorafenib,AAC,0.16581584084096,0.002514216311215,651,pan-cancer mRNA,CTRPv2,NPC-26,AAC,-0.116749967362061,0.00300354719316273,493,pan-cancer mRNA,CTRPv2,neratinib,AAC,-0.104745965554108,0.00326300859406863,488,pan-cancer mRNA,CTRPv2,Compound 7d-cis,AAC,-0.109388686872814,0.00347448611252598,244,pan-cancer mRNA,GDSC1000,PIK-93,AAC,-0.0830505395917181,0.0041664640300435,561,pan-cancer mRNA,CTRPv2,Doxorubicin,AAC,-0.0855090496302284,0.00463878961644621,273,pan-cancer mRNA,GDSC1000,YM-155,AAC,-0.0935703336920614,0.00535998359810765,752,pan-cancer mRNA,CTRPv2,KPT185,AAC,-0.107187521320185,0.00559246606212716,406,pan-cancer mRNA,gCSI,Bortezomib,AAC,-0.163701866817366,0.00572305570413835,92,pan-cancer mRNA,CTRPv2,ISOX:bortezomib (250:1 mol/mol),AAC,-0.096577167496182,0.00606744457880251,372,pan-cancer mRNA,CTRPv2,Obatoclax Mesylate,AAC,-0.0922574732197932,0.00697204223279043,514,pan-cancer mRNA,CTRPv2,CIL41,AAC,-0.139076580160343,0.00702194793357065,231,pan-cancer mRNA,GDSC1000,AT-7519,AAC,-0.0788497748673671,0.00806337472855335,39,pan-cancer mRNA,CTRPv2,CIL56,AAC,-0.120394665141857,0.00880761455522172,234,pan-cancer mRNA,CTRPv2,PF-184,AAC,-0.0874166759820285,0.00910544679513765,542,pan-cancer mRNA,GDSC1000,piperlongumine,AAC,-0.0864192149941413,0.00919975517736775,562,pan-cancer mRNA,CTRPv2,BRD1812,AAC,-0.0924411392388691,0.00936996032708097,177,pan-cancer mRNA,CTRPv2,Curcumin,AAC,-0.0895133327125809,0.0100073086516146,252,pan-cancer mRNA,CTRPv2,UNC0638,AAC,-0.0944512279498907,0.010047664251596,711,pan-cancer mRNA,CTRPv2,epigallocatechin-3-monogallate,AAC,-0.0939635592874187,0.0101129037776632,281,pan-cancer mRNA,GDSC1000,NSC-207895,AAC,-0.0861106443221063,0.0105478874230195,496,pan-cancer mRNA,CTRPv2,blebbistatin,AAC,-0.184666866199172,0.0106842673943228,83,pan-cancer mRNA,GDSC1000,GSK-650394,AAC,0.0915671633695293,0.0107449710414404,324,pan-cancer mRNA,CTRPv2,ciclopirox,AAC,-0.083733246634371,0.0111056125513387,228,pan-cancer mRNA,CTRPv2,GW-405833,AAC,0.0878546358108628,0.0113252176415182,344,pan-cancer mRNA,GDSC1000,SB 505124,AAC,-0.0869525725522499,0.0120492148126784,608,pan-cancer mRNA,GDSC1000,BX-795,AAC,0.0854834714641944,0.0127590601721343,189,pan-cancer mRNA,CTRPv2,WZ8040,AAC,-0.0970043265925116,0.0134071793839789,738,pan-cancer mRNA,CTRPv2,Parthenolide,AAC,-0.0952848864147644,0.0141062478530235,531,pan-cancer mRNA,CTRPv2,BRD-K92856060,AAC,-0.0886861937401497,0.0147930697207451,169,pan-cancer mRNA,CTRPv2,tipifarnib,AAC,-0.0765754756898753,0.0151782594112121,690,pan-cancer mRNA,GDSC1000,Methotrexate,AAC,0.0715196259756982,0.0152654437794205,438,pan-cancer mRNA,CTRPv2,SRT-1720,AAC,-0.0906753845592783,0.0156643050891735,657,pan-cancer mRNA,CTRPv2,ML312,AAC,-0.174148050652333,0.0157023786319606,459,pan-cancer mRNA,GDSC1000,CGP-60474,AAC,-0.127428280950416,0.0160396888972863,218,pan-cancer mRNA,CTRPv2,BRD-K52037352,AAC,-0.0983034221035288,0.0164277122293201,148,pan-cancer mRNA,CTRPv2,canertinib,AAC,-0.0877816998594792,0.0166763537807782,196,pan-cancer mRNA,CTRPv2,BRD-K26531177,AAC,-0.0883889019420415,0.0175742047368331,120,pan-cancer mRNA,GDSC1000,AZD7762,AAC,0.0760100658815777,0.0192775770836264,58,pan-cancer mRNA,CTRPv2,BRD-K86535717,AAC,-0.168742862540981,0.0195434349272064,166,pan-cancer mRNA,CTRPv2,sirolimus:bortezomib (250:1 mol/mol),AAC,-0.0795660980748651,0.0195927289540297,640,pan-cancer mRNA,CTRPv2,ML203,AAC,0.0877766509285992,0.0217970925273328,454,pan-cancer mRNA,CTRPv2,BRD-K49290616,AAC,-0.167889547211396,0.0222396904036118,144,pan-cancer mRNA,CTRPv2,avrainvillamide,AAC,-0.0943705478211234,0.0229109253598733,46,pan-cancer mRNA,CTRPv2,BIX-01294,AAC,-0.0786688140393771,0.0236926016995381,81,pan-cancer mRNA,CTRPv2,sitagliptin,AAC,-0.163582651573473,0.0237608025583386,641,pan-cancer mRNA,CTRPv2,L-685458,AAC,-0.0838823968415261,0.0245002398735981,413,pan-cancer mRNA,GDSC1000,Axitinib,AAC,0.0805809543522786,0.0247293361459993,47,pan-cancer mRNA,CTRPv2,MG-132,AAC,-0.134172697579941,0.0259779238442408,440,pan-cancer mRNA,CTRPv2,BRD9876:MK-1775 (4:1 mol/mol),AAC,0.254107088446811,0.0262064862988812,185,pan-cancer mRNA,CTRPv2,BI-2536,AAC,0.0704981040364465,0.0265268464994998,74,pan-cancer mRNA,CTRPv2,importazole,AAC,-0.0866441208391347,0.0266070343357622,362,pan-cancer mRNA,GDSC1000,PHA-665752,AAC,0.117841799439571,0.0267335597663813,554,pan-cancer mRNA,GDSC1000,CUDC-101,AAC,-0.0692738492745084,0.0269917454141812,251,pan-cancer mRNA,CTRPv2,BRD-K75293299,AAC,-0.156978983961927,0.0275220284408866,160,pan-cancer mRNA,CTRPv2,austocystin d,AAC,-0.0823824273126377,0.0276493171566427,43,pan-cancer mRNA,CTRPv2,doxorubicin:navitoclax (2:1 mol/mol),AAC,-0.0723994951640137,0.0283916151145958,274,pan-cancer mRNA,CTRPv2,BRD-K96970199,AAC,-0.155085675158202,0.0301299095111604,172,pan-cancer mRNA,GDSC1000,GW-2580,AAC,-0.076036106986556,0.0303784166385376,343,pan-cancer mRNA,CTRPv2,CCT036477,AAC,-0.0730999709495044,0.0310611234389392,207,pan-cancer mRNA,GDSC1000,GSK2126458,AAC,-0.0690855508411809,0.0311611507632341,332,pan-cancer mRNA,CTRPv2,SB-525334,AAC,-0.0803721113717465,0.0320893629454036,612,pan-cancer mRNA,CTRPv2,GMX-1778,AAC,-0.0767668510055572,0.032462022431999,319,pan-cancer mRNA,CTRPv2,AA-COCF3,AAC,-0.0768683231195614,0.0329630311772852,13,pan-cancer mRNA,CTRPv2,GSK1120212,AAC,-0.10435179738973,0.0333138685173909,329,pan-cancer mRNA,GDSC1000,TL-1-85,AAC,0.0643618038487508,0.0334625344544674,695,pan-cancer mRNA,CTRPv2,temsirolimus,AAC,-0.102866961014647,0.0335783180900021,680,pan-cancer mRNA,CTRPv2,BRD-K96431673,AAC,-0.151038603476784,0.0337751824668798,171,pan-cancer mRNA,CTRPv2,STF-31,AAC,-0.0756278185914834,0.0344776166580789,660,pan-cancer mRNA,CTRPv2,FSC231,AAC,-0.147870826450621,0.0357448760033586,305,pan-cancer mRNA,GDSC1000,A-443654,AAC,-0.111946352245463,0.0362380474987047,10,pan-cancer mRNA,CTRPv2,QS11,AAC,0.149403078028938,0.036598996467292,586,pan-cancer mRNA,GDSC1000,PD-0332991,AAC,0.0724208569848563,0.0371097570563077,536,pan-cancer mRNA,GDSC1000,KIN001-102,AAC,0.0625624692650283,0.0378295989423441,398,pan-cancer mRNA,CCLE,AEW541,AAC,0.0958098925256814,0.0379180215156067,21,pan-cancer mRNA,GDSC1000,YK 4-279,AAC,0.0762003140158034,0.0382130745526926,750,pan-cancer mRNA,FIMM,Roscovitine,AAC,-0.353492699968007,0.0382555871697362,600,pan-cancer mRNA,CTRPv2,MLN2480,AAC,-0.111517366221501,0.0383315526180708,463,pan-cancer mRNA,CTRPv2,BRD-A86708339,AAC,-0.105245531014516,0.0391876565495371,99,pan-cancer mRNA,CTRPv2,Rapamycin,AAC,-0.0710372272393763,0.0395013452896583,591,pan-cancer mRNA,CCLE,Nilotinib,AAC,0.103078470767585,0.040971547013372,491,pan-cancer mRNA,GDSC1000,Cyclopamine,AAC,-0.110178956965887,0.0412020691127615,255,pan-cancer mRNA,CTRPv2,BRD-K44224150,AAC,-0.152922756320718,0.0412791180208701,140,pan-cancer mRNA,CTRPv2,PF-750,AAC,-0.0784949068939165,0.0425795508894576,552,pan-cancer mRNA,CTRPv2,FGIN-1-27,AAC,-0.144695753557664,0.0426981578229719,295,pan-cancer mRNA,CCLE,RAF265,AAC,0.09986868716038,0.0433646603430449,590,pan-cancer mRNA,CTRPv2,BRD-K27986637,AAC,-0.144443559032953,0.0433807287528259,124,pan-cancer mRNA,CTRPv2,triptolide,AAC,-0.0721569820579246,0.0436805391799294,706,pan-cancer mRNA,CTRPv2,carboplatin:etoposide (40:17 mol/mol),AAC,-0.0604048393174859,0.0441750971872644,198,pan-cancer mRNA,CTRPv2,GSK2636771,AAC,-0.0875360921044384,0.0451809774084757,334,pan-cancer mRNA,CTRPv2,BRD-K58730230,AAC,0.145513478222603,0.0452358174889826,151,pan-cancer mRNA,GDSC1000,Tamoxifen,AAC,-0.0683523628618417,0.0465090037754538,673,pan-cancer mRNA,CTRPv2,ML258,AAC,-0.075284358838457,0.0465473273684867,457,pan-cancer mRNA,CTRPv2,Topotecan,AAC,-0.0638059978787607,0.0469815402060444,697,pan-cancer mRNA,CTRPv2,SNX-2112,AAC,-0.0634275247323598,0.0475675906837051,649,pan-cancer mRNA,CTRPv2,selumetinib:piperlongumine (8:1 mol/mol),AAC,-0.0702123407378761,0.0492613492143001,624,pan-cancer mRNA,CTRPv2,prochlorperazine,AAC,-0.073362609640934,0.0494000240400929,574,pan-cancer mRNA,GDSC1000,ZM-447439,AAC,0.071826324772302,0.0508193759649488,758,pan-cancer mRNA,GDSC1000,BMS-754807,AAC,0.0663189655839487,0.051313189472789,91,pan-cancer mRNA,CTRPv2,BRD9647,AAC,-0.0734825417006,0.0516625682661211,183,pan-cancer mRNA,GDSC1000,SB52334,AAC,-0.0648535621238511,0.052228679056837,614,pan-cancer mRNA,CTRPv2,compound 1B,AAC,0.07528865273128,0.0531544188228987,242,pan-cancer mRNA,GDSC1000,Y-39983,AAC,-0.0618849488818697,0.055975801776057,749,pan-cancer mRNA,CTRPv2,etomoxir,AAC,-0.0726359671359824,0.0587640078938766,289,pan-cancer mRNA,GDSC1000,HG-5-88-01,AAC,-0.0882836307960376,0.0588973830730208,349,pan-cancer mRNA,GDSC1000,FH535,AAC,0.065496724032798,0.0591808847523012,296,pan-cancer mRNA,CTRPv2,Axitinib,AAC,0.0650498221293556,0.0595361969484342,47,pan-cancer mRNA,CTRPv2,AZD6482,AAC,-0.0693891274181389,0.0611318793058017,57,pan-cancer mRNA,GDSC1000,Bryostatin 1,AAC,0.0662847602139843,0.0613920447340562,188,pan-cancer mRNA,GDSC1000,ATRA,AAC,0.0634491708465047,0.0624473240574238,42,pan-cancer mRNA,GDSC1000,CAL-101,AAC,-0.0593068370787767,0.0624752817597575,194,pan-cancer mRNA,CTRPv2,simvastatin,AAC,-0.0739067316149737,0.0630504488220323,639,pan-cancer mRNA,FIMM,serdemetan,AAC,-0.297867721432238,0.0645702460559139,630,pan-cancer mRNA,GDSC1000,PHA-793887,AAC,-0.0531609603117166,0.0647333410190968,555,pan-cancer mRNA,GDSC1000,KU-55933,AAC,0.0654712892896451,0.0661763235012568,409,pan-cancer mRNA,CTRPv2,BRD-K09587429,AAC,-0.0741283145713667,0.0675088880478637,109,pan-cancer mRNA,CTRPv2,BRD-K16130065,AAC,0.132150214796953,0.0683725314108619,114,pan-cancer mRNA,GDSC1000,Erlotinib,AAC,0.0899258885989167,0.06843676988069,287,pan-cancer mRNA,GDSC1000,embelin,AAC,0.0647911975320352,0.0696119210198163,280,pan-cancer mRNA,CTRPv2,SCH-79797,AAC,0.0643545518002159,0.0696326932761821,617,pan-cancer mRNA,GDSC1000,LY317615,AAC,0.0622912865665308,0.0698754158189938,431,pan-cancer mRNA,CTRPv2,cyanoquinoline 11,AAC,-0.0922466011407881,0.0716578013163838,254,pan-cancer mRNA,CTRPv2,BRD-K24690302,AAC,0.0665980048298088,0.0720361930733318,119,pan-cancer mRNA,CTRPv2,BRD-K78574327,AAC,-0.128989015412998,0.0735818912109549,161,pan-cancer mRNA,CTRPv2,BIBW2992,AAC,-0.0659799232243687,0.0743062974768268,76,pan-cancer mRNA,CTRPv2,BRD-K64610608,AAC,0.0693896971727625,0.0760660793708023,154,pan-cancer mRNA,GDSC1000,shikonin,AAC,-0.0610819027836469,0.0767115438948379,634,pan-cancer mRNA,GDSC1000,Lisitinib,AAC,0.0609627049365104,0.0771747593329948,425,pan-cancer mRNA,GDSC1000,RO-3306,AAC,0.0613356716502581,0.078802030823307,598,pan-cancer mRNA,CTRPv2,ruxolitinib,AAC,0.0612449580644373,0.0789333137805175,602,pan-cancer mRNA,GDSC1000,Cetuximab,AAC,0.05800624086272,0.0792193667347589,214,pan-cancer mRNA,CTRPv2,ABT-888,AAC,-0.0649495336298291,0.0803266332077529,18,pan-cancer mRNA,CTRPv2,ML006,AAC,-0.0656798685359814,0.0805750213672134,449,pan-cancer mRNA,CTRPv2,VAF-347,AAC,0.0825430011866218,0.0808692851152891,714,pan-cancer mRNA,CTRPv2,NSC23766,AAC,-0.0615830206867054,0.081338246321496,499,pan-cancer mRNA,CTRPv2,NVP-231,AAC,-0.0569358929737481,0.0818215794538044,509,pan-cancer mRNA,CTRPv2,BEC,AAC,-0.125526382791885,0.0820392373238889,68,pan-cancer mRNA,CTRPv2,PHA-793887,AAC,-0.0552079471604451,0.0826810298204223,555,pan-cancer mRNA,CTRPv2,HLI 373,AAC,-0.0624167878991391,0.0839905881653395,351,pan-cancer mRNA,CTRPv2,BRD-K55473186,AAC,0.0815132984904022,0.0845646177521028,150,pan-cancer mRNA,CTRPv2,staurosporine,AAC,-0.123619430481042,0.084828947975643,658,pan-cancer mRNA,GDSC1000,CAY10603,AAC,-0.0525401395095287,0.0848719294026071,202,pan-cancer mRNA,UHNBreast,AZD6244,AAC,0.49466081056203,0.0857098307346805,56,pan-cancer mRNA,CTRPv2,VU0155056,AAC,-0.0646529668671796,0.0888145520760058,728,pan-cancer mRNA,GDSC1000,VNLG/124,AAC,0.0555294103627133,0.0897828108452607,723,pan-cancer mRNA,CTRPv2,ML320,AAC,-0.061642560151752,0.0901828858146678,460,pan-cancer mRNA,CTRPv2,carboplatin:UNC0638 (2:1 mol/mol),AAC,-0.0643471450216053,0.0913640896530894,199,pan-cancer mRNA,FIMM,lenalidomide,AAC,-0.288195859350135,0.0923226723593884,419,pan-cancer mRNA,CTRPv2,BRD-K07442505,AAC,-0.0628698699417313,0.0943430181961998,107,pan-cancer mRNA,CTRPv2,SN-38,AAC,-0.0618634534342592,0.094621753906538,647,pan-cancer mRNA,GDSC1000,JW-7-24-1,AAC,-0.0494459623373294,0.0983083423214614,391,pan-cancer mRNA,CTRPv2,ATRA,AAC,0.058185128589889,0.0985559986981849,42,pan-cancer mRNA,CTRPv2,ibrutinib,AAC,-0.069556293818456,0.0996073157158134,356,pan-cancer mRNA,CTRPv2,BRD-K30019337,AAC,-0.114092352567531,0.0998991881051123,128,pan-cancer mRNA,CTRPv2,JW-74,AAC,-0.0763158751187893,0.100772568274994,393,pan-cancer mRNA,CTRPv2,BRD-K01737880,AAC,0.195023402485277,0.101391474790946,101,pan-cancer mRNA,GDSC1000,lapatinib,AAC,0.0795717073398561,0.101773771361927,415,pan-cancer mRNA,GDSC1000,Cytarabine,AAC,0.0578374929349755,0.101967509361742,257,pan-cancer mRNA,CTRPv2,BRD-K29313308,AAC,-0.0611324701409372,0.103430715121763,127,pan-cancer mRNA,GDSC1000,AZD8055,AAC,0.0545534873976309,0.103612999188918,59,pan-cancer mRNA,CTRPv2,RAF265,AAC,-0.0666709720058709,0.105743945763609,590,pan-cancer mRNA,CTRPv2,elocalcitol,AAC,-0.0564328999746952,0.10610829972338,279,pan-cancer mRNA,CTRPv2,Oxaliplatin,AAC,-0.053824513335253,0.107075093066372,523,pan-cancer mRNA,GDSC1000,ZSTK474,AAC,-0.0500581251205311,0.109170480350147,759,pan-cancer mRNA,CTRPv2,Bleomycin,AAC,-0.0607075706090907,0.109800082688264,84,pan-cancer mRNA,CTRPv2,KW-2449,AAC,0.0488468585047975,0.11004016735734,411,pan-cancer mRNA,CTRPv2,BRD-K88742110,AAC,-0.0586008645239675,0.111756003070021,167,pan-cancer mRNA,CTRPv2,semagacestat,AAC,-0.0597848594174432,0.112076701401874,629,pan-cancer mRNA,GDSC1000,PFI-1,AAC,-0.0532318320163429,0.112520581020146,553,pan-cancer mRNA,GDSC1000,Bexarotene,AAC,0.057023769932965,0.114491425455242,72,pan-cancer mRNA,GDSC1000,JW-7-52-1,AAC,-0.0838236843253036,0.11699102783237,392,pan-cancer mRNA,CTRPv2,Dasatinib,AAC,-0.0570502207828857,0.117500956757424,262,pan-cancer mRNA,CTRPv2,AGK-2,AAC,-0.0597058713844399,0.118617116620182,24,pan-cancer mRNA,CCLE,PLX4720,AAC,-0.0687171053595844,0.119652638931421,569,pan-cancer mRNA,CTRPv2,isoliquiritigenin,AAC,0.0998748418653428,0.121636262244819,369,pan-cancer mRNA,CTRPv2,selumetinib:UNC0638 (4:1 mol/mol),AAC,-0.0550781693989906,0.122170385681623,627,pan-cancer mRNA,CTRPv2,Vorinostat,AAC,-0.051400306669987,0.122733896464298,725,pan-cancer mRNA,GDSC1000,GSK429286A,AAC,-0.0507430240398934,0.123392034284134,337,pan-cancer mRNA,GDSC1000,dabrafenib,AAC,-0.046860051016807,0.123562625146185,259,pan-cancer mRNA,CTRPv2,tivantinib,AAC,0.0694571359913396,0.123777077166212,692,pan-cancer mRNA,GDSC1000,AP-24534,AAC,0.0519464200679815,0.12389997673313,32,pan-cancer mRNA,GDSC1000,BMS-509744,AAC,-0.0824334662281753,0.123931522477896,88,pan-cancer mRNA,GDSC1000,AC220,AAC,0.0536992473343737,0.12432454909913,19,pan-cancer mRNA,CTRPv2,BRD-K03536150,AAC,-0.0574906221349043,0.126417113858095,104,pan-cancer mRNA,GDSC1000,CX-5461,AAC,-0.0489569001310113,0.126675184559918,253,pan-cancer mRNA,gCSI,bid1870,AAC,-0.0844219388356575,0.126814366910935,78,pan-cancer mRNA,GDSC1000,TGX221,AAC,0.0731061963044857,0.126875803762309,684,pan-cancer mRNA,CTRPv2,BRD-K02492147,AAC,-0.0624545895141156,0.127015434920088,103,pan-cancer mRNA,CTRPv2,fluvastatin,AAC,-0.0565509850269301,0.128158268695711,299,pan-cancer mRNA,CTRPv2,MK-0752,AAC,0.0585774248401504,0.130035550497236,447,pan-cancer mRNA,CTRPv2,momelotinib,AAC,0.0527975889824808,0.131208120071311,465,pan-cancer mRNA,GDSC1000,Midostaurin,AAC,0.0524991852572717,0.133764276922285,444,pan-cancer mRNA,CTRPv2,TPCA-1,AAC,0.0493539257837602,0.134545818150833,699,pan-cancer mRNA,GDSC1000,GNF-2,AAC,0.0808572756614584,0.13476394951451,320,pan-cancer mRNA,CTRPv2,vorapaxar,AAC,-0.0565715532367587,0.137780168841693,724,pan-cancer mRNA,GDSC1000,CEP-701,AAC,0.048922252726885,0.137783157537211,211,pan-cancer mRNA,CTRPv2,BMS-195614,AAC,-0.0573802634849253,0.137790020935424,85,pan-cancer mRNA,CCLE,Vandetanib,AAC,0.0698959384694406,0.137893567715999,717,pan-cancer mRNA,CTRPv2,BRD-K11533227,AAC,-0.0560167458572404,0.138057472286125,110,pan-cancer mRNA,CTRPv2,ISOX,AAC,-0.0477230919185347,0.138089527590998,371,pan-cancer mRNA,CTRPv2,Bexarotene,AAC,0.0542228616712788,0.138851549141161,72,pan-cancer mRNA,CTRPv2,cediranib,AAC,-0.0795242562258192,0.139703524928534,210,pan-cancer mRNA,CTRPv2,selumetinib:MK-2206 (8:1 mol/mol),AAC,-0.0527681515576639,0.140534635171309,622,pan-cancer mRNA,GDSC1000,PLX4720,AAC,-0.0455299760906335,0.140601280684885,569,pan-cancer mRNA,CTRPv2,16-beta-bromoandrosterone,AAC,-0.0557223438765153,0.141507148367436,2,pan-cancer mRNA,GDSC1000,THZ-2-102-1,AAC,-0.0448668700061145,0.14255100902587,687,pan-cancer mRNA,GDSC1000,XMD13-2,AAC,-0.0461633010177271,0.143987261312988,743,pan-cancer mRNA,CTRPv2,BRD-K51831558,AAC,-0.0777869427720915,0.144008187813332,147,pan-cancer mRNA,GDSC1000,Z-LLNle-CHO,AAC,-0.0724092181297852,0.145102907849793,754,pan-cancer mRNA,CTRPv2,sotrastaurin,AAC,-0.0581394983062331,0.145268253180415,652,pan-cancer mRNA,FIMM,Vandetanib,AAC,0.263245917833345,0.147449230437104,717,pan-cancer mRNA,CTRPv2,UNC0321,AAC,-0.0542644592838848,0.147469992169126,710,pan-cancer mRNA,CTRPv2,AZD-2281,AAC,-0.0508642828293302,0.148069935568048,51,pan-cancer mRNA,CTRPv2,ETP-46464,AAC,-0.0624211075836217,0.148677914306681,291,pan-cancer mRNA,CTRPv2,tubastatin A,AAC,-0.0718475328362904,0.1487723031219,707,pan-cancer mRNA,GDSC1000,masitinib,AAC,0.0468539863820051,0.150883736769535,434,pan-cancer mRNA,CTRPv2,GSK461364,AAC,0.0457938123040461,0.151756672881125,338,pan-cancer mRNA,GDSC1000,Epothilone B,AAC,0.0501899754294152,0.153621486238916,283,pan-cancer mRNA,CTRPv2,NVP-BEZ235,AAC,-0.0608591250035098,0.153833174886757,511,pan-cancer mRNA,GDSC1000,AS605240,AAC,-0.0475917033896511,0.154090353449022,37,pan-cancer mRNA,GDSC1000,linifanib,AAC,0.0497888238162097,0.157849648192651,424,pan-cancer mRNA,FIMM,Bosutinib,AAC,-0.539153216220221,0.158144223061009,93,pan-cancer mRNA,CTRPv2,968,AAC,-0.0952394874446449,0.158411380767871,9,pan-cancer mRNA,GDSC1000,SB590885,AAC,-0.0457579126211066,0.158641629589045,615,pan-cancer mRNA,CTRPv2,tretinoin:navitoclax (4:1 mol/mol),AAC,0.0497745161103781,0.159497194080884,701,pan-cancer mRNA,CCLE,PD-0332991,AAC,0.0675611616572333,0.1597781011279,536,pan-cancer mRNA,GDSC1000,STF-62247,AAC,0.0465280174281942,0.159813636468727,661,pan-cancer mRNA,CTRPv2,BRD-K41334119,AAC,-0.101199818417732,0.16205586609335,137,pan-cancer mRNA,GDSC1000,THZ-2-49,AAC,0.0417565952576435,0.162325751822239,688,pan-cancer mRNA,CTRPv2,OSI-906,AAC,-0.0498258795314164,0.163366337174686,519,pan-cancer mRNA,CTRPv2,IPR-456,AAC,-0.0534829988217471,0.163511959719074,366,pan-cancer mRNA,CTRPv2,BRD8899,AAC,-0.053560175868889,0.164837713764748,181,pan-cancer mRNA,FIMM,temsirolimus,AAC,0.229805946819493,0.169652235044663,680,pan-cancer mRNA,GDSC1000,SGC0946,AAC,-0.0488712974527099,0.170662716929161,632,pan-cancer mRNA,CTRPv2,SU11274,AAC,-0.0488863519039512,0.171213712787611,662,pan-cancer mRNA,CTRPv2,silmitasertib,AAC,-0.0535962705870278,0.171602239691292,638,pan-cancer mRNA,GDSC1000,AKT inhibitor VIII,AAC,0.0473110949617554,0.173952494872467,26,pan-cancer mRNA,CTRPv2,OSI-930,AAC,0.0502855647571686,0.175510263677614,520,pan-cancer mRNA,GDSC1000,tivozanib,AAC,0.046887824201432,0.176335021741706,693,pan-cancer mRNA,CTRPv2,lovastatin,AAC,-0.0502120732772913,0.178775079086043,427,pan-cancer mRNA,CTRPv2,TAE684,AAC,-0.0475696519178904,0.179874589345111,669,pan-cancer mRNA,GDSC1000,QL-XII-61,AAC,-0.0648265456436257,0.180875992479812,585,pan-cancer mRNA,CTRPv2,N9-isopropylolomoucine,AAC,-0.0489185134251736,0.181072491811239,472,pan-cancer mRNA,CTRPv2,BRD-M00053801,AAC,-0.063982493382198,0.183628108386572,176,pan-cancer mRNA,GDSC1000,Pazopanib,AAC,0.0458038384352518,0.186252508351107,533,pan-cancer mRNA,GDSC1000,QL-VIII-58,AAC,-0.0615839103520207,0.186288897117624,581,pan-cancer mRNA,CTRPv2,CIL55,AAC,-0.0799766989766522,0.186771619019255,232,pan-cancer mRNA,GDSC1000,GSK-1904529A,AAC,-0.0448691032779634,0.187057574362834,322,pan-cancer mRNA,CTRPv2,Docetaxel,AAC,0.064020607723851,0.188118033675437,271,pan-cancer mRNA,FIMM,lapatinib,AAC,0.225666267431028,0.188547183775245,415,pan-cancer mRNA,GDSC1000,JNJ-26854165,AAC,0.0446961898374815,0.190840406425597,379,pan-cancer mRNA,CTRPv2,chlorambucil,AAC,-0.0415221029290427,0.191541702382963,224,pan-cancer mRNA,CTRPv2,CR-1-31B,AAC,-0.0427077401997938,0.192533196134745,247,pan-cancer mRNA,GDSC1000,Pyrimethamine,AAC,0.0700778859866711,0.192554547619509,580,pan-cancer mRNA,CTRPv2,pac-1,AAC,-0.0471400401066358,0.193010680250052,525,pan-cancer mRNA,CCLE,TAE684,AAC,0.0587388482602736,0.193890071913931,669,pan-cancer mRNA,CTRPv2,SNX-2112:bortezomib (250:1 mol/mol),AAC,-0.0428025206971822,0.194821504486492,650,pan-cancer mRNA,GDSC1000,VX-702,AAC,0.0456480137509087,0.196611630513121,731,pan-cancer mRNA,CTRPv2,SB-743921,AAC,0.0427120301001089,0.197037578529269,613,pan-cancer mRNA,GDSC1000,XMD8-92,AAC,-0.0612685857713914,0.19790537697449,747,pan-cancer mRNA,CTRPv2,ouabain,AAC,-0.0453754823864078,0.198986435085858,522,pan-cancer mRNA,CTRPv2,spautin-1,AAC,0.0485226124129166,0.201009047866883,653,pan-cancer mRNA,CTRPv2,PF-543,AAC,-0.0484680527819888,0.201903244396442,549,pan-cancer mRNA,CTRPv2,BIRB 0796,AAC,-0.0489444732902482,0.203504763613733,79,pan-cancer mRNA,CTRPv2,BRD-A02303741:carboplatin (1:1 mol/mol),AAC,0.0483967164742545,0.204848645518198,95,pan-cancer mRNA,CTRPv2,JW-55,AAC,-0.101904291438997,0.206162625578246,390,pan-cancer mRNA,CTRPv2,BRD-K16147474,AAC,-0.050466004919365,0.206634641110685,115,pan-cancer mRNA,CTRPv2,BRD-K51490254,AAC,-0.0480128477450721,0.20695859434098,146,pan-cancer mRNA,CTRPv2,selumetinib:PLX-4032 (8:1 mol/mol),AAC,-0.0448953348957228,0.208460663621557,625,pan-cancer mRNA,CTRPv2,RO4929097,AAC,-0.0678814018083946,0.208604497969745,599,pan-cancer mRNA,GDSC1000,ZG-10,AAC,-0.056920516713633,0.209682658213379,756,pan-cancer mRNA,FIMM,BI-2536,AAC,0.167461417382907,0.209902147248065,74,pan-cancer mRNA,GDSC1000,KIN001-244,AAC,-0.0394515573852237,0.210773989102311,401,pan-cancer mRNA,CCLE,Topotecan,AAC,0.053593322631042,0.212048207319743,697,pan-cancer mRNA,GDSC1000,GSK690693,AAC,-0.0402890235509388,0.212226974709777,340,pan-cancer mRNA,GDSC1000,OSU-03012,AAC,0.043271113454841,0.212903858119903,521,pan-cancer mRNA,GDSC1000,RDEA119,AAC,-0.0380760409065778,0.217205985865111,592,pan-cancer mRNA,CTRPv2,selumetinib:GDC-0941 (4:1 mol/mol),AAC,-0.0445834351273264,0.218835520733409,620,pan-cancer mRNA,CTRPv2,CAL-101,AAC,-0.0453572597527097,0.219284097957267,194,pan-cancer mRNA,CTRPv2,WAY-362450,AAC,-0.0461182384763541,0.222934818455593,732,pan-cancer mRNA,FIMM,Bexarotene,AAC,0.195744093341382,0.22368342393563,72,pan-cancer mRNA,CTRPv2,salermide,AAC,-0.0569077731700279,0.224472123336104,604,pan-cancer mRNA,GDSC1000,HG-6-64-1,AAC,0.0417472626917389,0.224487382791824,350,pan-cancer mRNA,GDSC1000,SB 216763,AAC,0.0458914795414763,0.227476098669151,607,pan-cancer mRNA,CTRPv2,VER-155008,AAC,-0.0438947849095041,0.228614178801739,719,pan-cancer mRNA,CCLE,Nutlin-3,AAC,0.0570778528194212,0.229805714673634,507,pan-cancer mRNA,GDSC1000,Sunitinib,AAC,0.0632968560086447,0.229827464264276,663,pan-cancer mRNA,GDSC1000,CMK,AAC,-0.0652552283639367,0.234685033456703,239,pan-cancer mRNA,CTRPv2,TG-100-115,AAC,-0.0444035293618675,0.234757889653854,682,pan-cancer mRNA,CTRPv2,BRD-K48334597,AAC,-0.0785086312096044,0.235449953586255,142,pan-cancer mRNA,CTRPv2,BRD-K27188169:navitoclax (2:1 mol/mol),AAC,0.0623779076526946,0.235461718851499,122,pan-cancer mRNA,CTRPv2,navitoclax:MST-312 (1:1 mol/mol),AAC,-0.0435814048120651,0.236544299357939,477,pan-cancer mRNA,CTRPv2,NVP-ADW742,AAC,-0.0419144446513707,0.236790284722296,510,pan-cancer mRNA,CTRPv2,BIBR-1532,AAC,0.0440856600999963,0.236976627072264,75,pan-cancer mRNA,FIMM,MS-275,AAC,-0.163979024711642,0.237915397807462,468,pan-cancer mRNA,CTRPv2,DBeQ,AAC,-0.0437829533944028,0.238646576886303,263,pan-cancer mRNA,CTRPv2,XL765,AAC,-0.0448100828265005,0.238923879088784,741,pan-cancer mRNA,CTRPv2,ML050,AAC,-0.0445427479484441,0.23912523898176,451,pan-cancer mRNA,CTRPv2,MI-1,AAC,-0.0466704636611533,0.239985132709071,442,pan-cancer mRNA,GDSC1000,Dasatinib,AAC,0.0596722615385289,0.242422355219407,262,pan-cancer mRNA,UHNBreast,paclitaxel,AAC,0.365038067814631,0.243313579742689,526,pan-cancer mRNA,CTRPv2,BRD-K03911514,AAC,0.0612678182263688,0.245254344876719,105,pan-cancer mRNA,CTRPv2,Imatinib,AAC,0.0426000891476099,0.247034076621026,361,pan-cancer mRNA,CTRPv2,SKI-II,AAC,-0.0428436197403279,0.249299521977455,644,pan-cancer mRNA,CTRPv2,Compound 1541A,AAC,-0.0453652699010515,0.250111610046772,241,pan-cancer mRNA,GDSC1000,JQ12,AAC,0.0405637103236747,0.250556194474577,388,pan-cancer mRNA,CTRPv2,OSI-027,AAC,-0.0406961815218761,0.252335378003182,518,pan-cancer mRNA,CTRPv2,Mitomycin-C,AAC,0.0383876184702959,0.254845901315464,445,pan-cancer mRNA,CTRPv2,GSK525762A,AAC,-0.0342788132608773,0.255198733187726,339,pan-cancer mRNA,CTRPv2,PRL-3 Inhibitor I,AAC,-0.0439269588992926,0.256585344757129,572,pan-cancer mRNA,CTRPv2,selumetinib:JQ-1 (4:1 mol/mol),AAC,-0.0396097421619082,0.256758167459873,621,pan-cancer mRNA,CTRPv2,purmorphamine,AAC,-0.0432006028824967,0.257619663385632,575,pan-cancer mRNA,CTRPv2,BRD-K27188169,AAC,-0.0600080399598515,0.257780040273603,121,pan-cancer mRNA,CTRPv2,nelarabine,AAC,0.0443938557680324,0.258520264937551,485,pan-cancer mRNA,GDSC1000,BX-912,AAC,-0.0341954337595572,0.259114587535525,190,pan-cancer mRNA,FIMM,paclitaxel,AAC,0.159548089315137,0.259654520620976,526,pan-cancer mRNA,CTRPv2,CI-976,AAC,0.044349907061043,0.259925075185056,227,pan-cancer mRNA,GDSC1000,Rapamycin,AAC,-0.0579718050398923,0.261686257631949,591,pan-cancer mRNA,CTRPv2,VX-680,AAC,0.120232695673707,0.263757574826542,730,pan-cancer mRNA,CTRPv2,BRD-K79669418,AAC,0.0587436657868289,0.265033779688595,162,pan-cancer mRNA,CTRPv2,BRD-K20514654,AAC,0.0562954577134538,0.265453478756882,118,pan-cancer mRNA,GDSC1000,NSC-87877,AAC,0.0398176814406524,0.267391644511515,497,pan-cancer mRNA,FIMM,Cyclopamine,AAC,-0.171410412818319,0.267760474208929,255,pan-cancer mRNA,CTRPv2,GSK1059615,AAC,-0.0511472938150477,0.268446288483128,326,pan-cancer mRNA,GDSC1000,VX-11e,AAC,-0.0369399631453871,0.269044477262723,729,pan-cancer mRNA,CTRPv2,tosedostat,AAC,-0.0409830705991892,0.269103398698408,698,pan-cancer mRNA,GDSC1000,GSK1070916,AAC,-0.0352083318497934,0.269895586726779,328,pan-cancer mRNA,CTRPv2,ifosfamide,AAC,0.0593655372883847,0.269965561232948,359,pan-cancer mRNA,CTRPv2,linifanib,AAC,0.039694741947823,0.27374991216521,424,pan-cancer mRNA,CTRPv2,BRD6340,AAC,-0.0385010826853895,0.274519559477334,180,pan-cancer mRNA,GDSC1000,AS601245,AAC,0.0382600281209243,0.277667706158123,36,pan-cancer mRNA,CTRPv2,MK-2206,AAC,-0.0395480770469017,0.278273474361989,448,pan-cancer mRNA,CTRPv2,CHIR-99021,AAC,-0.03659050978786,0.279368099437985,223,pan-cancer mRNA,GDSC1000,DMOG,AAC,0.0355458099630615,0.280308049344835,270,pan-cancer mRNA,CTRPv2,JQ-1:vorinostat (2:1 mol/mol),AAC,-0.0361748904083015,0.280530275609565,387,pan-cancer mRNA,CTRPv2,Tamoxifen,AAC,-0.0413263233533341,0.280607940165256,673,pan-cancer mRNA,CTRPv2,Vandetanib,AAC,-0.0394007543418974,0.284282405504613,717,pan-cancer mRNA,GDSC1000,LAQ824,AAC,0.0367785512952955,0.284603339791381,416,pan-cancer mRNA,CTRPv2,oligomycin a,AAC,-0.0385383093113825,0.284818930023551,515,pan-cancer mRNA,CTRPv2,apicidin,AAC,-0.0336038212962698,0.285060189069086,33,pan-cancer mRNA,GDSC1000,IPA-3,AAC,-0.0356338251848602,0.285156984194655,365,pan-cancer mRNA,CTRPv2,CD-1530,AAC,-0.040812364205188,0.288033409389122,208,pan-cancer mRNA,gCSI,Erlotinib,AAC,-0.0598606692614183,0.288875046219228,287,pan-cancer mRNA,CTRPv2,BRD4132,AAC,-0.0407797207779865,0.289005639736542,179,pan-cancer mRNA,GDSC1000,MLN4924,AAC,0.0419171669788523,0.289995334973256,464,pan-cancer mRNA,FIMM,GDC-0941,AAC,0.201524023867297,0.290190660828668,313,pan-cancer mRNA,GDSC1000,AZD6482,AAC,-0.0341983756021058,0.290491556016933,57,pan-cancer mRNA,GDSC1000,WZ3105,AAC,-0.0314965456870579,0.29519684595859,736,pan-cancer mRNA,CTRPv2,BRD-K41597374,AAC,0.037235740297373,0.29618078555083,138,pan-cancer mRNA,CTRPv2,BRD-K66532283,AAC,-0.035284460343439,0.296230069308115,156,pan-cancer mRNA,CTRPv2,BYL-719,AAC,-0.0455322108363793,0.297279601181807,191,pan-cancer mRNA,CTRPv2,YL54,AAC,-0.0413053447762741,0.29756027511843,751,pan-cancer mRNA,CTRPv2,bafilomycin A1,AAC,0.138756418388646,0.297840619801985,61,pan-cancer mRNA,CTRPv2,itraconazole,AAC,-0.040226370923694,0.299470068421905,376,pan-cancer mRNA,CCLE,L-685458,AAC,0.046896727205395,0.303117408351792,413,pan-cancer mRNA,GDSC1000,NG-25,AAC,0.030746977942333,0.304263418337972,489,pan-cancer mRNA,CTRPv2,AZD4547,AAC,0.0393635279380507,0.309450227354351,55,pan-cancer mRNA,CTRPv2,FK866,AAC,-0.0388922685063207,0.30989683999575,298,pan-cancer mRNA,CTRPv2,serdemetan:SCH-529074 (1:1 mol/mol),AAC,-0.0360453326895262,0.310597724329655,631,pan-cancer mRNA,GDSC1000,WZ-1-84,AAC,-0.0534027609883357,0.311399821261494,735,pan-cancer mRNA,GDSC1000,Talazoparib,AAC,0.0341779120710753,0.311844138488627,671,pan-cancer mRNA,GDSC1000,AZ628,AAC,0.0502133072802393,0.312614531406889,49,pan-cancer mRNA,CTRPv2,SCH-529074,AAC,-0.038338458792691,0.317963623599724,616,pan-cancer mRNA,CTRPv2,C6-ceramide,AAC,-0.0375634351539895,0.318144636300186,192,pan-cancer mRNA,CTRPv2,nintedanib,AAC,-0.0372786090368392,0.322477589864106,492,pan-cancer mRNA,CTRPv2,marinopyrrole A,AAC,0.0445399465045773,0.322760576078086,433,pan-cancer mRNA,CTRPv2,leptomycin B,AAC,-0.0335862882016208,0.323055338319327,421,pan-cancer mRNA,CTRPv2,GSK-J4,AAC,-0.102604940916747,0.326018589234234,325,pan-cancer mRNA,CCLE,PHA-665752,AAC,-0.0463086900017907,0.326373416397087,554,pan-cancer mRNA,GDSC1000,Vorinostat,AAC,0.0300250816063349,0.33262140248562,725,pan-cancer mRNA,CTRPv2,hyperforin,AAC,0.0380316606988728,0.333222795227695,352,pan-cancer mRNA,CTRPv2,I-BET151,AAC,-0.0301479644389414,0.333945556251069,354,pan-cancer mRNA,CTRPv2,selumetinib:vorinostat (8:1 mol/mol),AAC,-0.0355368372042988,0.334298817282651,628,pan-cancer mRNA,CTRPv2,pluripotin,AAC,-0.0343618043519617,0.336467442477885,567,pan-cancer mRNA,CCLE,Crizotinib,AAC,0.044086928052293,0.337762164872413,248,pan-cancer mRNA,GDSC1000,JQ-1,AAC,0.0314964079492494,0.341071558519444,382,pan-cancer mRNA,GDSC1000,Camptothecin,AAC,-0.0322208881224608,0.341991816155256,195,pan-cancer mRNA,CTRPv2,PRIMA-1-Met,AAC,-0.0504361450188657,0.343099784999712,571,pan-cancer mRNA,CTRPv2,brivanib,AAC,0.0342415096803093,0.343209960799561,187,pan-cancer mRNA,CTRPv2,PD318088,AAC,-0.0334052228223154,0.345732771708438,538,pan-cancer mRNA,gCSI,thapsigargin,AAC,0.0531534317602825,0.346128983809074,686,pan-cancer mRNA,FIMM,AZD-2281,AAC,-0.163996344236855,0.34836895738689,51,pan-cancer mRNA,CCLE,lapatinib,AAC,0.0418869788719414,0.348371515981197,415,pan-cancer mRNA,CTRPv2,HBX-41108,AAC,-0.0397123937772608,0.350017161818538,346,pan-cancer mRNA,CCLE,AZD0530,AAC,0.0443312944831632,0.35047276692168,53,pan-cancer mRNA,GDSC1000,Bosutinib,AAC,0.0312426227915009,0.351568159158923,93,pan-cancer mRNA,CTRPv2,niclosamide,AAC,-0.033958840297589,0.35194584129148,490,pan-cancer mRNA,GDSC1000,GDC-0449,AAC,0.0334266555870552,0.352148907950333,311,pan-cancer mRNA,CTRPv2,R428,AAC,-0.0406297025835793,0.353066123491714,589,pan-cancer mRNA,CTRPv2,Repligen 136,AAC,-0.0343893573973616,0.355429645501756,594,pan-cancer mRNA,CTRPv2,KU-55933,AAC,0.0339127750662714,0.355952009594348,409,pan-cancer mRNA,gCSI,MS-275,AAC,-0.0488899563060321,0.356784173744909,468,pan-cancer mRNA,GDSC1000,AR-42,AAC,-0.0281963445292856,0.357780163952679,34,pan-cancer mRNA,CCLE,Irinotecan,AAC,0.0495218847500239,0.35816841260463,367,pan-cancer mRNA,CTRPv2,BRD9876,AAC,0.0355061463405527,0.36014330753728,184,pan-cancer mRNA,CTRPv2,5-FU,AAC,0.031437027812689,0.360664521385452,7,pan-cancer mRNA,GDSC1000,Cisplatin,AAC,-0.0313582079172311,0.36095000785594,237,pan-cancer mRNA,GDSC1000,CCT007093,AAC,-0.0316749754508573,0.361000573415741,205,pan-cancer mRNA,CTRPv2,vincristine,AAC,-0.0281046036853311,0.361763202581066,721,pan-cancer mRNA,CTRPv2,PF-3758309,AAC,-0.0400406581031015,0.36248575640464,544,pan-cancer mRNA,GDSC1000,HG-5-113-01,AAC,0.0420700181308552,0.365072250982708,348,pan-cancer mRNA,CTRPv2,JQ-1:navitoclax (2:1 mol/mol),AAC,0.0310795646700961,0.366237328752858,385,pan-cancer mRNA,CTRPv2,Teniposide,AAC,-0.0361087178102329,0.367267340267245,681,pan-cancer mRNA,GDSC1000,KIN001-266,AAC,-0.0308817814983283,0.370877474964755,403,pan-cancer mRNA,CTRPv2,vorinostat:carboplatin (1:1 mol/mol),AAC,-0.0306960267621334,0.371013834272095,726,pan-cancer mRNA,CTRPv2,cabozantinib,AAC,0.0332044878908343,0.371122023675643,193,pan-cancer mRNA,CTRPv2,GDC-0879,AAC,-0.0317863987053497,0.376512274211203,312,pan-cancer mRNA,FIMM,RAF265,AAC,-0.160991669869852,0.378592886717548,590,pan-cancer mRNA,GDSC1000,Doxorubicin,AAC,-0.0315508400233508,0.379086511040901,273,pan-cancer mRNA,GDSC1000,XMD15-27,AAC,-0.0303301539906775,0.380769036456707,745,pan-cancer mRNA,GDSC1000,TG-101348,AAC,0.0250849386276841,0.381063607244105,683,pan-cancer mRNA,GDSC1000,MP470,AAC,-0.0302133678674941,0.381092412559955,466,pan-cancer mRNA,GDSC1000,AUY922,AAC,0.0309185775936104,0.381098855694249,44,pan-cancer mRNA,CTRPv2,salermide:PLX-4032 (12:1 mol/mol),AAC,-0.033101663830896,0.383002831723689,605,pan-cancer mRNA,GDSC1000,AICAR,AAC,0.0277780717845152,0.384937154377148,25,pan-cancer mRNA,CTRPv2,pitstop2,AAC,-0.0404247999895339,0.386810623414357,564,pan-cancer mRNA,CTRPv2,KX2-391,AAC,0.0280084417352393,0.38883584504443,412,pan-cancer mRNA,GDSC1000,KIN001-270,AAC,-0.0294190717359226,0.388928991332569,404,pan-cancer mRNA,CTRPv2,tivozanib,AAC,0.0318663174658546,0.38905494771528,693,pan-cancer mRNA,CTRPv2,WZ4002,AAC,-0.0383259412815585,0.389100370366136,737,pan-cancer mRNA,CTRPv2,dabrafenib,AAC,-0.0407798784241773,0.392906460759275,259,pan-cancer mRNA,CTRPv2,SR8278,AAC,-0.109201856630107,0.393120511019352,656,pan-cancer mRNA,CTRPv2,docetaxel:tanespimycin (2:1 mol/mol),AAC,0.0278696001295006,0.395858060220027,272,pan-cancer mRNA,GDSC1000,PF-4708671,AAC,-0.0296176709383735,0.396804317265503,547,pan-cancer mRNA,CCLE,Sorafenib,AAC,0.039751488054767,0.397574628556494,651,pan-cancer mRNA,FIMM,Cytarabine,AAC,-0.137777061215407,0.399116881003681,257,pan-cancer mRNA,CTRPv2,pandacostat,AAC,-0.0319700946148642,0.399158792106001,528,pan-cancer mRNA,CTRPv2,BRD-K84807411,AAC,-0.060738876436573,0.399493008271712,164,pan-cancer mRNA,FIMM,BIRB 0796,AAC,-0.161454612651189,0.400499196904906,79,pan-cancer mRNA,GDSC1000,Ispinesib Mesylate,AAC,-0.0268516910270607,0.40349803627496,374,pan-cancer mRNA,gCSI,Doxorubicin,AAC,-0.0427217100975527,0.405723557719128,273,pan-cancer mRNA,CTRPv2,tacedinaline,AAC,-0.0317790246676288,0.408098468353764,667,pan-cancer mRNA,CTRPv2,BMS-754807,AAC,-0.0288814315353884,0.410712455709804,91,pan-cancer mRNA,CTRPv2,3-Cl-AHPC,AAC,-0.0279672597398786,0.411996777196818,5,pan-cancer mRNA,CTRPv2,AZD7762,AAC,0.0272754815700199,0.412173754492452,58,pan-cancer mRNA,CTRPv2,BRD-K30748066,AAC,0.0969919314768479,0.416366321979647,129,pan-cancer mRNA,FIMM,Vorinostat,AAC,-0.133148789683775,0.418125442218923,725,pan-cancer mRNA,CTRPv2,QW-BI-011,AAC,-0.0546146418016394,0.41926065553726,588,pan-cancer mRNA,CTRPv2,HC-067047,AAC,0.0311218659259793,0.420030059873188,347,pan-cancer mRNA,CTRPv2,LY-2183240,AAC,-0.0259004100399491,0.420230120526072,430,pan-cancer mRNA,CTRPv2,Gemcitabine,AAC,-0.0268873348154567,0.420491377619655,316,pan-cancer mRNA,GDSC1000,FR-180204,AAC,0.0276549959429071,0.421401018512164,304,pan-cancer mRNA,CTRPv2,ABT-263,AAC,0.0288153218188934,0.422066464166447,16,pan-cancer mRNA,GDSC1000,QS11,AAC,0.0286541471246855,0.423538768381896,586,pan-cancer mRNA,CTRPv2,AT13387,AAC,-0.0371475740176825,0.425209139145057,40,pan-cancer mRNA,CTRPv2,Ki8751,AAC,0.0288851680343601,0.425914224934302,396,pan-cancer mRNA,GDSC1000,IOX2,AAC,-0.0269477396347844,0.429503310894387,364,pan-cancer mRNA,GDSC1000,CI-1040,AAC,-0.025998776707854,0.429653862442708,226,pan-cancer mRNA,GDSC1000,MS-275,AAC,0.0411685992536337,0.435613430046048,468,pan-cancer mRNA,CTRPv2,Carboplatin,AAC,-0.0285600198117868,0.435695700766932,197,pan-cancer mRNA,CTRPv2,AZD8055,AAC,0.0274744510104636,0.442193552421142,59,pan-cancer mRNA,CTRPv2,ZSTK474,AAC,-0.0287877306601056,0.444029266443885,759,pan-cancer mRNA,CTRPv2,etoposide,AAC,-0.0227106206757453,0.447975448664184,290,pan-cancer mRNA,CTRPv2,decitabine,AAC,0.021117276244986,0.45069526909092,264,pan-cancer mRNA,CTRPv2,KU 0060648,AAC,0.0270944259128045,0.450994185532701,407,pan-cancer mRNA,GDSC1000,CP466722,AAC,-0.0226178283842168,0.451348015098478,245,pan-cancer mRNA,GDSC1000,Obatoclax Mesylate,AAC,-0.0261395046072691,0.451517399539254,514,pan-cancer mRNA,GDSC1000,Vinorelbine,AAC,0.0267070410229603,0.451535535594105,722,pan-cancer mRNA,gCSI,paclitaxel,AAC,-0.0395496428046602,0.45415082670589,526,pan-cancer mRNA,CTRPv2,vorinostat:navitoclax (4:1 mol/mol),AAC,0.0266266407892761,0.455974423834244,727,pan-cancer mRNA,CTRPv2,Mdivi-1,AAC,0.0276638009288823,0.456157861508816,435,pan-cancer mRNA,CTRPv2,paclitaxel,AAC,0.024966287867357,0.456559598284737,526,pan-cancer mRNA,GDSC1000,KIN001-135,AAC,0.0408557973004312,0.459548580922524,399,pan-cancer mRNA,CTRPv2,selumetinib:tretinoin (2:1 mol/mol),AAC,-0.0265509609696496,0.459820430190235,626,pan-cancer mRNA,CTRPv2,navitoclax:pluripotin (1:1 mol/mol),AAC,0.0269200289152908,0.459846335640145,479,pan-cancer mRNA,CTRPv2,PF-573228,AAC,0.0250399066652423,0.464161561500516,551,pan-cancer mRNA,GDSC1000,LFM-A13,AAC,0.0256901436666717,0.465019393635169,423,pan-cancer mRNA,FIMM,Tipifarnib,AAC,-0.0992821382476044,0.46624300163052,691,pan-cancer mRNA,CTRPv2,BRD-K37390332,AAC,0.0287219898021135,0.466838809417641,136,pan-cancer mRNA,CTRPv2,BRD-K09344309,AAC,0.058899687778079,0.468945913381334,108,pan-cancer mRNA,CTRPv2,istradefylline,AAC,0.0403826851256109,0.470075091060181,375,pan-cancer mRNA,CTRPv2,Nilotinib,AAC,0.0269355180096302,0.471830779352178,491,pan-cancer mRNA,CTRPv2,SGX-523,AAC,-0.0270607874545205,0.47243765502021,633,pan-cancer mRNA,FIMM,Doxorubicin,AAC,-0.109603285592352,0.472591128864006,273,pan-cancer mRNA,GDSC1000,WH-4-023,AAC,0.036822006604027,0.473469308225441,733,pan-cancer mRNA,CTRPv2,Methotrexate,AAC,0.0265220759833165,0.476731445917689,438,pan-cancer mRNA,FIMM,BMS-754807,AAC,-0.0984754606026224,0.477198810293501,91,pan-cancer mRNA,CTRPv2,erlotinib:PLX-4032 (2:1 mol/mol),AAC,-0.0272104984891154,0.477541473338725,288,pan-cancer mRNA,CTRPv2,AC55649,AAC,-0.0271833831078516,0.480446040789286,20,pan-cancer mRNA,CTRPv2,quizartinib,AAC,-0.0265688308489035,0.480647436201252,587,pan-cancer mRNA,CTRPv2,B02,AAC,-0.0258424166261622,0.482384606131943,60,pan-cancer mRNA,CTRPv2,selumetinib:decitabine (4:1 mol/mol),AAC,-0.0239978174839216,0.483443784512332,619,pan-cancer mRNA,CTRPv2,GDC-0941,AAC,-0.0257189757050888,0.484381382181535,313,pan-cancer mRNA,CTRPv2,BRD-K42260513,AAC,0.0392572913512268,0.488455755841962,139,pan-cancer mRNA,CTRPv2,MS-275,AAC,-0.0226140784489949,0.489803782743203,468,pan-cancer mRNA,CTRPv2,BMS-536924,AAC,0.0249984308056457,0.490690857332853,89,pan-cancer mRNA,CTRPv2,BRD-K35604418,AAC,-0.0257889578743158,0.491322638585447,135,pan-cancer mRNA,CTRPv2,ML239,AAC,0.0248876248178848,0.491342105317886,456,pan-cancer mRNA,gCSI,GDC-0941,AAC,-0.041198968242573,0.492978451162456,313,pan-cancer mRNA,FIMM,Gefitinib,AAC,-0.115985039009021,0.493018941449664,314,pan-cancer mRNA,CTRPv2,RG-108,AAC,-0.0249124693482592,0.497565438291959,595,pan-cancer mRNA,CTRPv2,JQ-1:UNC0638 (2:1 mol/mol),AAC,-0.0237715812268835,0.497588386210498,386,pan-cancer mRNA,CTRPv2,Merck60,AAC,-0.0204988371839295,0.501622834959729,437,pan-cancer mRNA,GDSC1000,YM201636,AAC,0.0211317268913839,0.503913666719749,753,pan-cancer mRNA,CTRPv2,lomeguatrib,AAC,-0.0251192403610277,0.50393079610107,426,pan-cancer mRNA,CTRPv2,PF-4800567 hydrochloride,AAC,-0.0367979423607665,0.504296491655409,548,pan-cancer mRNA,gCSI,Docetaxel,AAC,-0.0356858005371767,0.506202874269948,271,pan-cancer mRNA,GDSC1000,KIN001-055,AAC,-0.0226927774312874,0.506718130847967,397,pan-cancer mRNA,FIMM,Epothilone B,AAC,0.116470647085281,0.508620064288006,283,pan-cancer mRNA,GDSC1000,I-BET-762,AAC,-0.0181843401230401,0.510946329363814,353,pan-cancer mRNA,GDSC1000,CP724714,AAC,-0.0222456999931727,0.51329817985029,246,pan-cancer mRNA,GDSC1000,681640,AAC,-0.0245992789895907,0.514376778969996,8,pan-cancer mRNA,CTRPv2,MGCD-265,AAC,-0.0226731790906477,0.51474072581582,441,pan-cancer mRNA,CTRPv2,alisertib:navitoclax (2:1 mol/mol),AAC,0.0230564366310562,0.517263401037088,28,pan-cancer mRNA,CTRPv2,BRD-K48477130,AAC,-0.0364354622264278,0.51733422712785,143,pan-cancer mRNA,FIMM,BIBW2992,AAC,0.106106665815256,0.518246666785797,76,pan-cancer mRNA,CTRPv2,lapatinib,AAC,-0.0233028628665198,0.520577553093935,415,pan-cancer mRNA,GDSC1000,Nutlin-3a (-),AAC,-0.0220281533789274,0.521136228971767,508,pan-cancer mRNA,GDSC1000,Tipifarnib,AAC,0.0230094752359575,0.521193947505988,691,pan-cancer mRNA,GDSC1000,EKB-569,AAC,-0.0211220556523793,0.523937324018607,276,pan-cancer mRNA,CTRPv2,BRD-K29086754,AAC,-0.0468957063935286,0.525616543932188,126,pan-cancer mRNA,GDSC1000,NVP-BEZ235,AAC,-0.0218814117133425,0.527861890528211,511,pan-cancer mRNA,CTRPv2,SR1001,AAC,0.0241147228848202,0.53090103478347,655,pan-cancer mRNA,GDSC1000,QL-XI-92,AAC,-0.0192037573428276,0.53548247018233,583,pan-cancer mRNA,GDSC1000,FMK,AAC,-0.0232041279060004,0.536831637012521,300,pan-cancer mRNA,CTRPv2,Bax channel blocker,AAC,-0.0236368995558983,0.538600538044495,65,pan-cancer mRNA,CTRPv2,BRD-K61166597,AAC,-0.019712241110517,0.539916265869373,152,pan-cancer mRNA,GDSC1000,CGP-082996,AAC,-0.0329070968974885,0.540247878423291,217,pan-cancer mRNA,CTRPv2,EX-527,AAC,-0.0239088799747635,0.542192847738196,293,pan-cancer mRNA,CTRPv2,BRD-A02303741:navitoclax (2:1 mol/mol),AAC,0.0221596604934478,0.542787946166681,96,pan-cancer mRNA,CTRPv2,isonicotinohydroxamic acid,AAC,-0.0288797981495926,0.542997753133128,370,pan-cancer mRNA,CTRPv2,Fumonisin B1,AAC,-0.0224766832078894,0.54746480402057,309,pan-cancer mRNA,GDSC1000,TL-2-105,AAC,0.0196443761526816,0.54797166968082,696,pan-cancer mRNA,CTRPv2,ELCPK,AAC,-0.0302606267575939,0.549117749984796,277,pan-cancer mRNA,GDSC1000,JNK Inhibitor VIII,AAC,-0.0207934938012273,0.549554547434666,380,pan-cancer mRNA,GDSC1000,UNC0638,AAC,-0.0178700828591155,0.551648963104341,711,pan-cancer mRNA,CTRPv2,isoevodiamine,AAC,0.0196508044959629,0.552517773277332,368,pan-cancer mRNA,GDSC1000,Bleomycin,AAC,0.0213770434288705,0.553580557077212,84,pan-cancer mRNA,CTRPv2,PLX4720,AAC,-0.0209683663365154,0.553823604609049,569,pan-cancer mRNA,CTRPv2,valdecoxib,AAC,-0.0213188352254815,0.554241717741978,715,pan-cancer mRNA,CTRPv2,tretinoin:carboplatin (2:1 mol/mol),AAC,0.0210343425173584,0.554735493522635,700,pan-cancer mRNA,CTRPv2,BRD-K50799972,AAC,0.022580173611425,0.55533844788991,145,pan-cancer mRNA,GDSC1000,paclitaxel,AAC,-0.0308124837686942,0.5562932107592,526,pan-cancer mRNA,CTRPv2,navitoclax:sorafenib (1:1 mol/mol),AAC,-0.0205473601984674,0.561122794805466,481,pan-cancer mRNA,GDSC1000,GW 441756,AAC,0.020454427322,0.563993399519088,342,pan-cancer mRNA,CTRPv2,KH-CB19,AAC,0.027075201991106,0.565771166975457,394,pan-cancer mRNA,gCSI,PD-0325901,AAC,0.0291677143626187,0.567795446900833,535,pan-cancer mRNA,CTRPv2,NSC 74859,AAC,-0.0222063054156762,0.568982553483534,495,pan-cancer mRNA,CTRPv2,triazolothiadiazine,AAC,0.017192896983418,0.569506040061973,702,pan-cancer mRNA,CTRPv2,necrostatin-1,AAC,0.0211542630737225,0.57439162291101,482,pan-cancer mRNA,CTRPv2,CIL70,AAC,-0.0268034187888695,0.575883206809404,235,pan-cancer mRNA,GDSC1000,EX-527,AAC,0.0195550748919381,0.576295385190431,293,pan-cancer mRNA,GDSC1000,pac-1,AAC,-0.0200992799721475,0.580710785905486,525,pan-cancer mRNA,FIMM,Sunitinib,AAC,-0.102179158830314,0.580802324364807,663,pan-cancer mRNA,CTRPv2,tandutinib,AAC,-0.0202247459942538,0.580825290991014,674,pan-cancer mRNA,CTRPv2,COL-3,AAC,-0.0208546637608569,0.584335338118412,240,pan-cancer mRNA,CTRPv2,MLN4924,AAC,-0.0188057708584765,0.586602461475021,464,pan-cancer mRNA,CTRPv2,myriocin,AAC,-0.0419209782641631,0.591066062237397,471,pan-cancer mRNA,GDSC1000,NU-7441,AAC,0.0193448229579679,0.593089410157233,505,pan-cancer mRNA,GDSC1000,ruxolitinib,AAC,0.0179965334523596,0.594016909498814,602,pan-cancer mRNA,GDSC1000,phenformin,AAC,-0.0166496049399276,0.595234633295555,556,pan-cancer mRNA,CTRPv2,FQI-2,AAC,0.0171740926039677,0.597687853387771,303,pan-cancer mRNA,CTRPv2,JNJ-26854165,AAC,-0.0179656063946007,0.600892355599961,379,pan-cancer mRNA,CTRPv2,bendamustine,AAC,-0.0198608709501678,0.603298029137004,70,pan-cancer mRNA,GDSC1000,MK-2206,AAC,0.018779460043923,0.605943430820738,448,pan-cancer mRNA,CTRPv2,procarbazine,AAC,0.0204877307458263,0.606401398665886,573,pan-cancer mRNA,GDSC1000,CCT018159,AAC,0.0178547644616338,0.606854700202513,206,pan-cancer mRNA,CTRPv2,clofarabine,AAC,-0.0149749889110049,0.610471797119311,238,pan-cancer mRNA,CTRPv2,AT7867,AAC,0.0181832836626888,0.611958876388647,41,pan-cancer mRNA,CTRPv2,trifluoperazine,AAC,-0.01993041580029,0.613266533929755,705,pan-cancer mRNA,CTRPv2,Erlotinib,AAC,0.017762461026912,0.613505290147139,287,pan-cancer mRNA,CTRPv2,pifithrin-alpha,AAC,-0.0190149928793597,0.614008738760367,559,pan-cancer mRNA,FIMM,Bryostatin 1,AAC,-0.0748878271927177,0.614143056969957,188,pan-cancer mRNA,FIMM,Axitinib,AAC,-0.0838340199573552,0.616216819764987,47,pan-cancer mRNA,CTRPv2,Bosutinib,AAC,-0.0175813545953735,0.616301990172717,93,pan-cancer mRNA,CTRPv2,LRRK2-IN-1,AAC,-0.0187759712490585,0.618677097471376,428,pan-cancer mRNA,CTRPv2,phloretin,AAC,0.0172755388666426,0.620902033231555,557,pan-cancer mRNA,GDSC1000,SNX-2112,AAC,-0.0149365539323739,0.621239650540054,649,pan-cancer mRNA,CTRPv2,BRD-K33199242,AAC,-0.0188620426179132,0.623120177949137,130,pan-cancer mRNA,CTRPv2,IU1,AAC,-0.0190777100519001,0.626489549482161,377,pan-cancer mRNA,GDSC1000,FK866,AAC,-0.0149744264175377,0.628730036761097,298,pan-cancer mRNA,CTRPv2,ciclosporin,AAC,0.0183280822531563,0.629673658077541,229,pan-cancer mRNA,CTRPv2,navitoclax:PLX-4032 (1:1 mol/mol),AAC,0.0170599608529094,0.632403913951241,480,pan-cancer mRNA,CTRPv2,narciclasine,AAC,-0.0159961295712004,0.632543247731519,474,pan-cancer mRNA,CTRPv2,NVP-BSK805,AAC,-0.0163267176618666,0.635164448507951,512,pan-cancer mRNA,CTRPv2,AZD6244,AAC,-0.0171947715703901,0.635947963851214,56,pan-cancer mRNA,GDSC1000,BIX02189,AAC,0.0148709306807682,0.638247637350696,82,pan-cancer mRNA,CTRPv2,ML334 diastereomer,AAC,-0.0212989922137134,0.640252756621051,461,pan-cancer mRNA,GDSC1000,BMS-708163,AAC,-0.0157535254164609,0.642882553981758,90,pan-cancer mRNA,FIMM,Pazopanib,AAC,0.0870534674742883,0.64729586415467,533,pan-cancer mRNA,CTRPv2,ABT-737,AAC,0.0167219860915061,0.648958011021401,17,pan-cancer mRNA,FIMM,AMG-706,AAC,0.0788690118208002,0.648996052191535,31,pan-cancer mRNA,FIMM,Bortezomib,AAC,0.0709613952964221,0.649556837116044,92,pan-cancer mRNA,gCSI,Vorinostat,AAC,0.023320757559351,0.650623950538612,725,pan-cancer mRNA,CTRPv2,masitinib,AAC,0.0166300761350165,0.651781800007685,434,pan-cancer mRNA,CTRPv2,KHS101,AAC,0.0169574716464386,0.651910914576743,395,pan-cancer mRNA,CTRPv2,CHEMBL1222381,AAC,-0.0150285329791385,0.654466931316459,221,pan-cancer mRNA,CTRPv2,BRD-K19103580,AAC,-0.0168873253958626,0.655365126117011,117,pan-cancer mRNA,CTRPv2,Sunitinib,AAC,-0.0155584342313917,0.65580794907097,663,pan-cancer mRNA,gCSI,Irinotecan,AAC,-0.0236693308613787,0.656248215712417,367,pan-cancer mRNA,FIMM,AP-24534,AAC,0.0782724067499196,0.660990405118207,32,pan-cancer mRNA,GDSC1000,BAY 61-3606,AAC,-0.0152415599387302,0.66129067943797,66,pan-cancer mRNA,GDSC1000,OSI-930,AAC,0.0151915557053839,0.661823656890007,520,pan-cancer mRNA,CTRPv2,BRD-K27224038,AAC,-0.0316169302296476,0.662375211603554,123,pan-cancer mRNA,FIMM,Bicalutamide,AAC,-0.0773219739654094,0.664519718784356,77,pan-cancer mRNA,CTRPv2,BRD-K63431240,AAC,0.0155354673231875,0.665663258857067,153,pan-cancer mRNA,GDSC1000,temsirolimus,AAC,-0.0145743138179729,0.66744804730712,680,pan-cancer mRNA,CTRPv2,BRD-K80183349,AAC,-0.0141056117510305,0.66753167395493,163,pan-cancer mRNA,CTRPv2,navitoclax:piperlongumine (1:1 mol/mol),AAC,-0.0155477748778852,0.6684437373029,478,pan-cancer mRNA,FIMM,RDEA119,AAC,0.0754650862606415,0.671692804360523,592,pan-cancer mRNA,CTRPv2,decitabine:carboplatin (1:1 mol/mol),AAC,-0.0121489393563196,0.672859878862735,265,pan-cancer mRNA,CTRPv2,BRD-K90370028,AAC,0.0234474971861491,0.673151301761337,168,pan-cancer mRNA,FIMM,AZD6244,AAC,-0.0779434916935042,0.673617750825985,56,pan-cancer mRNA,GDSC1000,SN-38,AAC,-0.014126435650772,0.67422063976644,647,pan-cancer mRNA,CTRPv2,TG-101348,AAC,-0.0141792826202526,0.676981501207115,683,pan-cancer mRNA,CTRPv2,StemRegenin 1,AAC,-0.0146269328960313,0.677320088220703,659,pan-cancer mRNA,CTRPv2,necrostatin-7,AAC,0.015214027827575,0.685431240898748,483,pan-cancer mRNA,CTRPv2,Gefitinib,AAC,-0.014772197780079,0.688412768670984,314,pan-cancer mRNA,CTRPv2,IC-87114,AAC,0.0149276295454762,0.69326326428464,357,pan-cancer mRNA,FIMM,S-Trityl-L-cysteine,AAC,0.0739562756079859,0.695345059129698,603,pan-cancer mRNA,GDSC1000,XMD14-99,AAC,-0.0130038563339622,0.696864600320656,744,pan-cancer mRNA,CTRPv2,BRD-K13999467,AAC,0.0142173996901265,0.69770814052305,112,pan-cancer mRNA,CTRPv2,tanespimycin:bortezomib (250:1 mol/mol),AAC,0.0146726187498658,0.698780435627875,675,pan-cancer mRNA,GDSC1000,S-Trityl-L-cysteine,AAC,-0.0204884575936303,0.699090766812369,603,pan-cancer mRNA,CTRPv2,selumetinib:BRD-A02303741 (4:1 mol/mol),AAC,-0.0136551773975028,0.699874190556369,618,pan-cancer mRNA,GDSC1000,Zibotentan,AAC,0.0129945915709433,0.700834415022994,757,pan-cancer mRNA,CTRPv2,SNS-032,AAC,-0.0137483538091376,0.702866072312976,648,pan-cancer mRNA,GDSC1000,MPS-1-IN-1,AAC,-0.0122246126566392,0.704171116329408,467,pan-cancer mRNA,CTRPv2,BMS-270394,AAC,0.0141618871486829,0.704863775850314,86,pan-cancer mRNA,CTRPv2,PIK-93,AAC,-0.0133389021178387,0.706119633622543,561,pan-cancer mRNA,CTRPv2,BRD-K99006945,AAC,0.0199069304564922,0.706789090917517,174,pan-cancer mRNA,GDSC1000,GW843682X,AAC,0.0200172448264629,0.70699920402858,345,pan-cancer mRNA,CCLE,Erlotinib,AAC,0.0170959604823016,0.708735524460929,287,pan-cancer mRNA,CTRPv2,azacitidine,AAC,-0.0142931535131828,0.709391709457253,50,pan-cancer mRNA,CTRPv2,crizotinib:PLX-4032 (2:1 mol/mol),AAC,-0.0129065846205336,0.711498178557245,249,pan-cancer mRNA,GDSC1000,tubastatin A,AAC,0.0114783995425633,0.711922996379459,707,pan-cancer mRNA,CTRPv2,PD 153035,AAC,-0.0156268456427969,0.712523223672613,534,pan-cancer mRNA,CTRPv2,BRD-K55116708,AAC,0.0134742634310003,0.714517287268303,149,pan-cancer mRNA,CTRPv2,rigosertib,AAC,-0.0121683907216543,0.715828026344118,596,pan-cancer mRNA,FIMM,Imatinib,AAC,-0.0666841873680197,0.720779910609361,361,pan-cancer mRNA,CTRPv2,ABT-199,AAC,0.0157452584117647,0.723181053104589,15,pan-cancer mRNA,CTRPv2,SJ-172550,AAC,-0.0135281197246598,0.726599169092873,642,pan-cancer mRNA,CTRPv2,BRD-K85133207,AAC,0.0128441687595741,0.73305778088821,165,pan-cancer mRNA,CTRPv2,AZ-3146,AAC,0.0121399405652809,0.733326106801542,48,pan-cancer mRNA,FIMM,Crizotinib,AAC,0.063679234284633,0.733384101741623,248,pan-cancer mRNA,CTRPv2,BRD-K14844214,AAC,-0.0132127000221694,0.737079899087699,113,pan-cancer mRNA,GDSC1000,Elesclomol,AAC,0.0114676335427054,0.737260778677146,278,pan-cancer mRNA,CTRPv2,JQ-1:MK-0752 (1:1 mol/mol),AAC,-0.0115384138330133,0.737371972461528,384,pan-cancer mRNA,GDSC1000,Bicalutamide,AAC,0.0113648889951796,0.737603672650934,77,pan-cancer mRNA,CTRPv2,JQ-1,AAC,0.0105759569960661,0.739866010992424,382,pan-cancer mRNA,FIMM,ABT-263,AAC,-0.0515681930736794,0.740179585775696,16,pan-cancer mRNA,CTRPv2,erismodegib,AAC,-0.0127237040620765,0.740271306507183,285,pan-cancer mRNA,CTRPv2,Compound 23 citrate,AAC,-0.0112086796949607,0.742692048294978,243,pan-cancer mRNA,CTRPv2,YK 4-279,AAC,-0.0105916594808586,0.742777235930365,750,pan-cancer mRNA,CTRPv2,Ko-143,AAC,-0.0121015131656823,0.745578931111828,405,pan-cancer mRNA,CTRPv2,BMS-345541,AAC,0.0116320012466456,0.750852312615793,87,pan-cancer mRNA,CTRPv2,BRD-K45681478,AAC,-0.0116361326518792,0.751032475504127,141,pan-cancer mRNA,CTRPv2,tamatinib,AAC,0.0119463631009412,0.752056563181833,672,pan-cancer mRNA,FIMM,Dasatinib,AAC,0.0541905880101151,0.752919771358914,262,pan-cancer mRNA,CTRPv2,fulvestrant,AAC,-0.023222195540798,0.75767322086712,308,pan-cancer mRNA,CTRPv2,SR-II-138A,AAC,-0.0098122799325342,0.758923411348088,654,pan-cancer mRNA,CTRPv2,gossypol,AAC,-0.011397435265455,0.760669402920903,321,pan-cancer mRNA,GDSC1000,Genentech Cpd 10,AAC,0.0095863813955478,0.761223615464008,317,pan-cancer mRNA,CTRPv2,LE-135,AAC,-0.0110181391312247,0.764407331223785,418,pan-cancer mRNA,GDSC1000,Gemcitabine,AAC,0.0105342722196514,0.765716649689891,316,pan-cancer mRNA,FIMM,Nilotinib,AAC,0.0538515779325664,0.766581166850367,491,pan-cancer mRNA,CTRPv2,KU-60019,AAC,0.0104961184345135,0.766942180817288,410,pan-cancer mRNA,CTRPv2,CHM-1,AAC,-0.00962914503358707,0.768988917158952,225,pan-cancer mRNA,CTRPv2,SB-225002,AAC,-0.00913348965479303,0.770181570052649,609,pan-cancer mRNA,CTRPv2,KU-0063794,AAC,-0.0104905865142089,0.770944273028348,408,pan-cancer mRNA,CTRPv2,dacarbazine,AAC,0.0093264060934566,0.771775478099567,260,pan-cancer mRNA,CTRPv2,Panobinostat,AAC,-0.00973994254298363,0.772662834777796,529,pan-cancer mRNA,CTRPv2,skepinone-L,AAC,-0.014911833064791,0.773127036254477,643,pan-cancer mRNA,CTRPv2,BRD-K70511574,AAC,0.00938791302601442,0.773189116078702,157,pan-cancer mRNA,CTRPv2,barasertib,AAC,-0.00915236629179592,0.779367136710453,63,pan-cancer mRNA,CTRPv2,birinapant,AAC,-0.0106332836734178,0.779783556875357,80,pan-cancer mRNA,GDSC1000,XMD8-85,AAC,-0.0144146336374486,0.783007824961754,746,pan-cancer mRNA,GDSC1000,FTI-277,AAC,-0.00942881406114316,0.783574841484135,307,pan-cancer mRNA,GDSC1000,TAE684,AAC,-0.0147337801718034,0.785596384361535,669,pan-cancer mRNA,CTRPv2,SB-431542,AAC,0.0103898181196468,0.786305826831056,611,pan-cancer mRNA,CTRPv2,CHEMBL374350,AAC,0.0103445147789409,0.786678759309839,222,pan-cancer mRNA,CTRPv2,Zebularine,AAC,0.00931559356764529,0.788448471750264,755,pan-cancer mRNA,GDSC1000,Docetaxel,AAC,0.00825579647585632,0.792603689698726,271,pan-cancer mRNA,CTRPv2,BRD-K66453893,AAC,-0.00831373704472252,0.793627691154823,155,pan-cancer mRNA,FIMM,Methotrexate,AAC,-0.0367281712367284,0.793733970688117,438,pan-cancer mRNA,GDSC1000,T0901317,AAC,0.00854549300959309,0.798556501739436,666,pan-cancer mRNA,GDSC1000,BMS-345541,AAC,0.0079724690079958,0.800231678045744,87,pan-cancer mRNA,GDSC1000,BMS-536924,AAC,0.0082572830579699,0.801683619964383,89,pan-cancer mRNA,GDSC1000,XL-184,AAC,0.00855759995008974,0.803612022068271,740,pan-cancer mRNA,CTRPv2,ceranib-2,AAC,0.00826305311196599,0.803851165668089,212,pan-cancer mRNA,FIMM,CEP-701,AAC,-0.0322879068981357,0.804125646205971,211,pan-cancer mRNA,gCSI,Rapamycin,AAC,0.013173123221531,0.810535445135664,591,pan-cancer mRNA,CTRPv2,BRD-K97651142,AAC,0.00897877969494692,0.812736440398945,173,pan-cancer mRNA,CTRPv2,CIL55A,AAC,-0.0115745135305493,0.817822977810823,233,pan-cancer mRNA,CTRPv2,lenvatinib,AAC,-0.00852671838762131,0.818630579492285,420,pan-cancer mRNA,CTRPv2,JQ-1:carboplatin (1:1 mol/mol),AAC,-0.00744055252254956,0.821912206753527,383,pan-cancer mRNA,GDSC1000,Bortezomib,AAC,-0.0111526122536872,0.82428183604124,92,pan-cancer mRNA,CTRPv2,neopeltolide,AAC,-0.0152875070911093,0.825278530243739,487,pan-cancer mRNA,CTRPv2,BRD-K04800985,AAC,-0.00824050734851415,0.82974631807624,106,pan-cancer mRNA,CTRPv2,parbendazole,AAC,-0.00668735094221139,0.831832880049262,530,pan-cancer mRNA,CTRPv2,Platin,AAC,0.00797711830987,0.833405101917663,566,pan-cancer mRNA,GDSC1000,XMD11-85h,AAC,-0.0101344109970288,0.835122728106458,742,pan-cancer mRNA,GDSC1000,TW 37,AAC,-0.00667052173082661,0.841547853473158,708,pan-cancer mRNA,CTRPv2,JW-480,AAC,0.00754896988200783,0.84344408185355,389,pan-cancer mRNA,FIMM,PD-0332991,AAC,-0.0342873823590407,0.84346035907414,536,pan-cancer mRNA,GDSC1000,AMG-706,AAC,-0.00691210136795071,0.844162661165437,31,pan-cancer mRNA,CTRPv2,tanespimycin:gemcitabine (1:1 mol/mol),AAC,0.00642789016266942,0.844480958905887,676,pan-cancer mRNA,UHNBreast,Erlotinib,AAC,0.0557751673544082,0.84979478812511,287,pan-cancer mRNA,CTRPv2,myricetin,AAC,-0.00724207787360977,0.851509348416485,470,pan-cancer mRNA,CTRPv2,navitoclax:gemcitabine (1:1 mol/mol),AAC,0.0063868575393146,0.851889800286373,476,pan-cancer mRNA,GDSC1000,NPK76-II-72-1,AAC,0.00548251215497327,0.853217378964799,494,pan-cancer mRNA,CTRPv2,BRD-A02303741,AAC,-0.0071754704235251,0.854078237252081,94,pan-cancer mRNA,GDSC1000,PD173074,AAC,-0.0065187662362608,0.854359585512165,537,pan-cancer mRNA,GDSC1000,foretinib,AAC,-0.00593372334074796,0.856163748184508,301,pan-cancer mRNA,CTRPv2,BRD1835,AAC,-0.00691897962942009,0.856503855183212,178,pan-cancer mRNA,CTRPv2,LY-2157299,AAC,-0.0132575223974353,0.857827034225607,429,pan-cancer mRNA,CTRPv2,UNC0638:navitoclax (1:1 mol/mol),AAC,0.00657944020457685,0.858933857843981,712,pan-cancer mRNA,GDSC1000,Roscovitine,AAC,0.00954108086733688,0.859025984057273,600,pan-cancer mRNA,CTRPv2,PDMP,AAC,0.00671556395088284,0.859930134286542,540,pan-cancer mRNA,CTRPv2,tacrolimus,AAC,0.00613256818373742,0.863624976448066,668,pan-cancer mRNA,gCSI,Gemcitabine,AAC,-0.00951787362992885,0.863841331002967,316,pan-cancer mRNA,GDSC1000,MG-132,AAC,0.00853281712702839,0.864407741608763,440,pan-cancer mRNA,CTRPv2,cimetidine,AAC,0.0112851477247826,0.865122631695447,236,pan-cancer mRNA,CTRPv2,BRD-K33514849,AAC,-0.0216272377475548,0.866086232913423,131,pan-cancer mRNA,GDSC1000,TPCA-1,AAC,-0.00487876156872297,0.866718399931042,699,pan-cancer mRNA,FIMM,Panobinostat,AAC,0.0202654463739257,0.867835632189164,529,pan-cancer mRNA,CTRPv2,navitoclax:birinapant (1:1 mol/mol),AAC,-0.0060353846548308,0.869098050926123,475,pan-cancer mRNA,GDSC1000,BI-2536,AAC,-0.00872938117825452,0.871104212807501,74,pan-cancer mRNA,CTRPv2,SZ4TA2,AAC,-0.00888758810765729,0.87157700876366,665,pan-cancer mRNA,GDSC1000,GDC-0941,AAC,0.00538855437026832,0.872362656641077,313,pan-cancer mRNA,CTRPv2,darinaparsin,AAC,-0.00813800970021662,0.874628138768948,261,pan-cancer mRNA,CTRPv2,nakiterpiosin,AAC,0.00528403658360619,0.875214164232397,473,pan-cancer mRNA,GDSC1000,Gefitinib,AAC,0.00516331282035455,0.875485981414243,314,pan-cancer mRNA,CTRPv2,BRD8958,AAC,0.00616585394118106,0.87602457105128,182,pan-cancer mRNA,GDSC1000,Vinblastine,AAC,0.00524886119070818,0.87775895724175,720,pan-cancer mRNA,CTRPv2,tigecycline,AAC,-0.00747103091278421,0.877977806488491,689,pan-cancer mRNA,CTRPv2,alisertib,AAC,-0.00487171777349636,0.878214961024839,27,pan-cancer mRNA,GDSC1000,EHT 1864,AAC,0.00527676858339853,0.878660936742765,275,pan-cancer mRNA,CTRPv2,decitabine:navitoclax (2:1 mol/mol),AAC,0.00476072471221326,0.880203024444773,266,pan-cancer mRNA,GDSC1000,Salubrinal,AAC,-0.00799994073832352,0.880883455819585,606,pan-cancer mRNA,GDSC1000,XAV-939,AAC,-0.00519571969552107,0.881043799275015,739,pan-cancer mRNA,CTRPv2,AM-580,AAC,-0.00547919254818122,0.884051070331995,30,pan-cancer mRNA,CTRPv2,CAY10594,AAC,-0.00553548092005616,0.88468980826279,201,pan-cancer mRNA,GDSC1000,etoposide,AAC,-0.00498722692517323,0.88797246737588,290,pan-cancer mRNA,CTRPv2,CID-5951923,AAC,-0.00534450016497824,0.889845242702184,230,pan-cancer mRNA,CTRPv2,thalidomide,AAC,0.00742512544730693,0.891273813259179,685,pan-cancer mRNA,CTRPv2,indisulam,AAC,0.00442265422338554,0.891656009284166,363,pan-cancer mRNA,CTRPv2,Crizotinib,AAC,0.00444256382860942,0.892040314292705,248,pan-cancer mRNA,CTRPv2,Sildenafil,AAC,-0.0050978639964955,0.895027631142206,637,pan-cancer mRNA,GDSC1000,Crizotinib,AAC,-0.0071849637861638,0.895095701481357,248,pan-cancer mRNA,CTRPv2,Nutlin-3,AAC,-0.00455724398028582,0.896042242312862,507,pan-cancer mRNA,CTRPv2,BRD-K71781559,AAC,0.0050814724017441,0.897046243864067,158,pan-cancer mRNA,GDSC1000,A-770041,AAC,0.00686503775945506,0.89743023659261,11,pan-cancer mRNA,CCLE,LBW242,AAC,0.00616800956485316,0.89752584275993,417,pan-cancer mRNA,GDSC1000,TAK-715,AAC,-0.00415892846347069,0.899238713188303,670,pan-cancer mRNA,FIMM,GDC-0449,AAC,0.0232250059611055,0.89958748226885,311,pan-cancer mRNA,CTRPv2,CD-437,AAC,-0.00406388310553071,0.900658963662043,209,pan-cancer mRNA,CTRPv2,BRD-K99584050,AAC,0.00664815562259304,0.900916860392758,175,pan-cancer mRNA,CTRPv2,BRD-K34485477,AAC,0.00923645604628956,0.902482754936433,134,pan-cancer mRNA,GDSC1000,GSK269962A,AAC,-0.00394650142570573,0.904018299118091,335,pan-cancer mRNA,CTRPv2,CBB-1007,AAC,-0.00653338714597679,0.90522271470325,204,pan-cancer mRNA,CTRPv2,GSK4112,AAC,-0.00438895579753291,0.906699456862397,336,pan-cancer mRNA,gCSI,lapatinib,AAC,-0.00628042411294423,0.907526197624979,415,pan-cancer mRNA,GDSC1000,UNC1215,AAC,0.0040376911404375,0.90763446503799,713,pan-cancer mRNA,CTRPv2,alvocidib,AAC,0.00541570748938922,0.912534276683625,29,pan-cancer mRNA,GDSC1000,CHIR-99021,AAC,0.00350553861490602,0.913006908940592,223,pan-cancer mRNA,CTRPv2,foretinib,AAC,-0.00371259674001774,0.917240908134478,301,pan-cancer mRNA,CTRPv2,BCL-LZH-4,AAC,-0.0051325688423319,0.92424734124335,67,pan-cancer mRNA,CTRPv2,BRD-A71883111,AAC,-0.00349668777648993,0.92579647141612,98,pan-cancer mRNA,UHNBreast,lapatinib,AAC,-0.0281291026463963,0.927319134864042,415,pan-cancer mRNA,CTRPv2,AZD-7545,AAC,-0.00335269342555308,0.928090248511956,52,pan-cancer mRNA,GDSC1000,Parthenolide,AAC,-0.00479330576748124,0.928792332413455,531,pan-cancer mRNA,FIMM,Erlotinib,AAC,0.0157138523298358,0.928938109547618,287,pan-cancer mRNA,CTRPv2,BRD-K28456706,AAC,-0.00303988170774876,0.934256971116565,125,pan-cancer mRNA,CTRPv2,CAY10576,AAC,0.00326372762736912,0.934992260506144,200,pan-cancer mRNA,GDSC1000,VX-680,AAC,-0.00437582211321973,0.935881364024614,730,pan-cancer mRNA,GDSC1000,lenalidomide,AAC,0.00287501743762183,0.936341794280072,419,pan-cancer mRNA,CTRPv2,BRD-A94377914,AAC,-0.0033429284714851,0.939080607975973,100,pan-cancer mRNA,FIMM,Sorafenib,AAC,0.013401824112707,0.940170288164821,651,pan-cancer mRNA,CTRPv2,dinaciclib,AAC,0.0035988777312891,0.941089631653089,268,pan-cancer mRNA,CTRPv2,ML311,AAC,-0.00220680633200443,0.946271184887244,458,pan-cancer mRNA,CCLE,PD-0325901,AAC,-0.00287065656270462,0.94633475057666,535,pan-cancer mRNA,CTRPv2,ML083,AAC,0.00227636934652225,0.953571337907657,452,pan-cancer mRNA,GDSC1000,AG-014699,AAC,-0.00185313567422396,0.956841125054739,22,pan-cancer mRNA,GDSC1000,PF-562271,AAC,-0.00179332368133723,0.958261760887918,550,pan-cancer mRNA,CTRPv2,BRD-K02251932,AAC,-0.00204286472618136,0.958482494158683,102,pan-cancer mRNA,FIMM,17-AAG,AAC,0.00955684868028195,0.959252228717181,3,pan-cancer mRNA,GDSC1000,KIN001-236,AAC,0.0016952644943421,0.960046300995405,400,pan-cancer mRNA,CTRPv2,TGX221,AAC,-0.00184272153189359,0.960692752026525,684,pan-cancer mRNA,FIMM,ATRA,AAC,-0.00777630755124271,0.961273582249117,42,pan-cancer mRNA,CTRPv2,BRD-A05715709,AAC,0.00264442159579226,0.962592365137793,97,pan-cancer mRNA,CTRPv2,avicin D,AAC,0.00254456751070252,0.962765242604247,45,pan-cancer mRNA,CTRPv2,MK 1775,AAC,0.00159465886143218,0.962873847377797,446,pan-cancer mRNA,gCSI,Crizotinib,AAC,-0.00260282281414084,0.963387667933226,248,pan-cancer mRNA,CTRPv2,palmostatin B,AAC,-0.00209159773072109,0.96360307815483,527,pan-cancer mRNA,CTRPv2,A-804598,AAC,0.00201042674311228,0.965743332697797,12,pan-cancer mRNA,GDSC1000,BIRB 0796,AAC,-0.0013860067276746,0.968653298530355,79,pan-cancer mRNA,FIMM,Irinotecan,AAC,0.00467149215019037,0.969079828048495,367,pan-cancer mRNA,GDSC1000,SL 0101-1,AAC,-0.00133484744970154,0.970665222919522,645,pan-cancer mRNA,GDSC1000,PD-0325901,AAC,-0.000999158943488813,0.975625370518622,535,pan-cancer mRNA,CTRPv2,MI-2,AAC,0.00143963596535124,0.978645825627921,443,pan-cancer mRNA,CTRPv2,GW843682X,AAC,-0.000701069093990583,0.984137332015243,345,pan-cancer mRNA,CTRPv2,betulinic acid,AAC,0.000747115157930507,0.984666922811071,71,pan-cancer mRNA,GDSC1000,CH5424802,AAC,0.000383836240194903,0.991021415673308,220,pan-cancer mRNA,CTRPv2,selumetinib:navitoclax (8:1 mol/mol),AAC,-0.000325171196949065,0.992981280430269,623,pan-cancer mRNA,CTRPv2,AT-406,AAC,-0.000403193532796409,0.993428674829381,38,pan-cancer mRNA,CTRPv2,Cytarabine,AAC,-0.000234677931784832,0.993464811379748,257,pan-cancer mRNA,CTRPv2,AZD1480,AAC,-0.000403342750967534,0.993999401539995,54,pan-cancer mRNA,CTRPv2,dexamethasone,AAC,-0.000215713492804034,0.994934249119907,267,pan-cancer mRNA,CTRPv2,BRD-K17060750,AAC,-0.000236054512493139,0.99503251754081,116,pan-cancer mRNA,CTRPv2,FQI-1,AAC,0.000277176345227564,0.995292916115863,302,pan-cancer mRNA,CTRPv2,regorafenib,AAC,0.000208515999007045,0.995619243130419,593,pan-cancer mRNA,GDSC1000,JNK-9L,AAC,0.000187962298256934,0.99578044204086,381,pan-cancer mRNA,FIMM,AZD0530,AAC,-0.000897780563277028,0.995837051370346,53,pan-cancer mRNA,CCLE,AZD6244,AAC,0.000199650618769327,0.996366825048501,56,pan-cancer mRNA,GDSC1000,KIN001-260,AAC,0.000111265691568647,0.997185462709846,402,pan-cancer mRNA,GDSC1000,BHG712,AAC,-8.34862180643862e-05,0.997780520120522,73,pan-cancer mRNA,FIMM,Topotecan,AAC,9.80578003161399e-05,0.999301443130089,697,pan-cancer mRNA,CTRPv2,AZD0530,AAC,2.11228280541125e-05,0.999542285130756,53,pan-cancer